Physician profile
Muhammad Raza
NPI 1043690290
$3,932.79
in general payments reported to CMS, 2019-2025
7 companies · $2,675 in 2025
The $2,675 reported for 2025 was more than what 93% of Periodontics providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $191 · 2021: $350 · 2022: $61.49 · 2023: $397 · 2024: $258 · 2025: $2,675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,500 · Food and Beverage: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,500.00 |
| Food and Beverage | $830.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,655.18 | 2020-2025 | Triclip, Aveir, Jot Dx |
| Amgen INC. | $144.20 | 2021-2025 | Repatha |
| Straumann USA LLC | $38.33 | 2023-2024 | |
| Orapharma, A Division of Bausch Health US, LLC | $34.06 | 2022-2024 | Arestin, Ossix Plus |
| Celgene Corporation | $23.86 | 2023 | Reblozyl |
| Geistlich Pharma, North America, INC. | $23.58 | 2024 | Geistlich Bio-Gide |
| Astrazeneca Pharmaceuticals LP | $13.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Raza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.